A Study of PRCL-02 in Moderate to Severe Chronic Plaque Psoriasis

NCT03614078 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Psoriasis Vulgaris
Plaque Psoriasis

Interventions

DRUG: PRCL-02
DRUG: Placebo

Sponsor

PRCL Research Inc.